ArticleBMC cancer2026

Comparative efficacy and safety of first-line immunotherapy- and targeted therapy-based regimens for advanced gastric and gastroesophageal junction cancer: a network meta-analysis.

Wanting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.